Identifying variants using high-throughput sequen-cing data is currently a challenge because true biological variants can be indistinguishable from technical artifacts. One source of technical arti-fact results from incorrectly aligning experimen-tally observed sequences to their true genomic origin (‘mismapping’) and inferring differences in mismapped sequences to be true variants. We de-veloped BlackOPs, an open-source tool that simu-lates experimental RNA-seq and DNA whole exome sequences derived from the reference genome, aligns these sequences by custom parameters, detects variants and outputs a blacklist of positions and alleles caused by mismapping. Blacklist
BackgroundTo facilitate the clinical implementation of genomic medicine by next-generation sequencin...
RNA sequencing (RNA-seq) has emerged as a powerful approach to discover disease-causing gene regulat...
RNA-seq (transcriptome sequencing) is primarily considered a method of gene expression analysis but ...
Identifying variants using high-throughput sequen-cing data is currently a challenge because true bi...
Identifying variants using high-throughput sequencing data is currently a challenge because true bio...
International audienceComputational analyses of human patient exomes aim to filter out as many nonpa...
<div><p>A diversity of tools is available for identification of variants from genome sequence data. ...
International audienceHigh-throughput sequencing technologies have become fundamental for the identi...
Computational tools are widely used for interpreting variants detected in sequencing projects. The c...
Exome and whole-genome analyses powered by next-generation sequencing (NGS) have become invaluable t...
MOTIVATION: Advances in sequencing technologies have remarkably lowered the detection limit of somat...
The primary function for RNA sequencing (RNA-seq) is to investigate the transcriptome through differ...
Over the past fifty years, the genetic bases for many human diseases have been discovered. Genome-wi...
<div><p>A critical step in detecting variants from next-generation sequencing data is <em>post hoc</...
A critical step in detecting variants from next-generation sequencing data is post hoc filtering of ...
BackgroundTo facilitate the clinical implementation of genomic medicine by next-generation sequencin...
RNA sequencing (RNA-seq) has emerged as a powerful approach to discover disease-causing gene regulat...
RNA-seq (transcriptome sequencing) is primarily considered a method of gene expression analysis but ...
Identifying variants using high-throughput sequen-cing data is currently a challenge because true bi...
Identifying variants using high-throughput sequencing data is currently a challenge because true bio...
International audienceComputational analyses of human patient exomes aim to filter out as many nonpa...
<div><p>A diversity of tools is available for identification of variants from genome sequence data. ...
International audienceHigh-throughput sequencing technologies have become fundamental for the identi...
Computational tools are widely used for interpreting variants detected in sequencing projects. The c...
Exome and whole-genome analyses powered by next-generation sequencing (NGS) have become invaluable t...
MOTIVATION: Advances in sequencing technologies have remarkably lowered the detection limit of somat...
The primary function for RNA sequencing (RNA-seq) is to investigate the transcriptome through differ...
Over the past fifty years, the genetic bases for many human diseases have been discovered. Genome-wi...
<div><p>A critical step in detecting variants from next-generation sequencing data is <em>post hoc</...
A critical step in detecting variants from next-generation sequencing data is post hoc filtering of ...
BackgroundTo facilitate the clinical implementation of genomic medicine by next-generation sequencin...
RNA sequencing (RNA-seq) has emerged as a powerful approach to discover disease-causing gene regulat...
RNA-seq (transcriptome sequencing) is primarily considered a method of gene expression analysis but ...